Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Andrew Saik
24 Jun 2026
Chief Financial Officer
Sold on a plan
5,696
$8.16
$46.47K
Angela M Cacace
17 Jun 2026
Chief Scientific Officer
Sold on a plan
2,576
$7.60
$19.56K

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 80
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 25,802,990
Sales filed before the plan box existed 81
History held since 28 Sep 2018